Characterisation and prognostic value of colorectal adenomas using molecular genetic markers;Caratterizzazione e valore prognostico degli adenomi colorettali mediante marcatori genetici molecolari

Minerva Chirurgica

Volumn 55, Issue 3, 2000, Pages 99-104

  Di Stefano, A ^a   Fisichella, P ^a,b   Catanuto, G ^a   Di Blasi, M ^a   La Greca, G ^a   Grasso, G ^a   Russello, D ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Aneuploidy; Colorectal neoplasms; DNA, neoplasms analysis; Flow cytometry; Ki 67 antigen; Prognosis; Proliferating cell nuclear antigen; Protein p 53

Indexed keywords

CYCLINE; KI 67 ANTIGEN; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COLON ADENOMA; COLORECTAL CANCER; DIGESTIVE TRACT ENDOSCOPY; DYSPLASIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; PATIENT MONITORING; PLOIDY; PROGNOSIS; STATISTICAL ANALYSIS;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034056908     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Liebermann D. Colon cancer screening overview. Proceedings of the American Gastroenterology Association. S. Francisco (USA), 1996:189-97.
2. Armitage NC, Robins RA, Evans DF, Turner DF, Baldwin RW, Hardcastle DJ. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985;72:828-30.
3. Sciallero S, Bruno S, Di Vinci A, Geido E, Aste W, Giaretti N. Flow citometry DNA ploidy in colorectal cancer. Cancer 1988;61:114-20.
4. Goh HS, Jass JR. DNA content and the adenoma-adenocarcinoma sequence in the colonrectum. J Clin Pathol 1986;39:387-92.
5. Kokal WA, Duda RB, Azumi N, Sheibani K, Kemeni MM, Terz JJ et al. Tumor DNA content in primary and metastatic colorectal carcinoma. Arch Surg 1986;121: 1434-9.
6. Hamada S, Itoh R, Fujita S. DNA distribution pattern of the so-called severe displasias and small carcinomas of the colon and rectum and its possible significance in the tumor progression. Cancer 1988;61:1555-62.
7. Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G, Nelson LT. Relationship among p-53, stage and prognosis of large bowel cancer. Dis Colon Rectum 1994;37(6):527-34.
8. Mulder JWR, Wielenga VJM, Polak MM, Van den Berg FM, Adolf GR, Herrlich P et al. Expression of mutant p-53 protein and CD 44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80.
9. Hemming AW, Davis NL, Kluftinger A, Robinson B, Quenville NF, Liseman B et al. Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor and ki-67. J Surg Oncol 1992;51:147-52.
10. Suzuki H, Matsumoto K, Terabe M. Ki-67 antibody labeling index in colorectal. J Clin Gastroenterol 1992;15(4):317-20.
11. Frei JV, Troster MM, Cramer HM, Martinez WJ, Cook M. DNA flow citometry of large bowel biopsies showing that adenoma tissue predicts the ultimate nature of the lesions. Can J Surg 1991;34(4):343-8.
12. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. Genetic alteration during colorectal-tumor development. N Engl J Med 1988;319: 525-32.
13. Paty PB, Genetic molecular for colorectal tumors. Proceedings of SSAT, S. Francisco (USA), 1996.
14. Offerhaus A, De Feyter EP, Cornelisse CJ, Tersmette K, Floyd J, Kern SE et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterol 1992;102:1612-9.